Loading clinical trials...
Loading clinical trials...
Phase I/II, Multicenter, Open-label, Single Administration, Dose Finding, Clinical Trial to Evaluate the Safety and Tolerability of Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration
Conditions
Interventions
Intradiscal rhGDF-5
Locations
8
United States
Spine Institute
Santa Monica, California, United States
Durango Orthopedic Associates/Spine Colorado
Durango, Colorado, United States
Drug Studies America
Marietta, Georgia, United States
Rehabilitation Institute of Chicago
Chicago, Illinois, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Riverhills Healthcare, Inc.
Cincinnati, Ohio, United States
Start Date
June 1, 2008
Primary Completion Date
June 1, 2013
Completion Date
June 1, 2013
Last Updated
February 26, 2016
NCT07254806
NCT05508360
NCT05037968
NCT05029726
NCT06011551
NCT06383949
Lead Sponsor
DePuy Spine
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions